Pediatric patients with vitiligo responded well to 308-nm laser treatment, with the best retention of re-pigmentation for facial lesions, according to a study published in the Journal of Drugs and Dermatology. Sumit Sethi, MBBS, MD, DNB, and Nanette B. Silverberg, MD, conducted a chart review of children undergoing active 308-nm laser in 2016. They recorded demographic data, therapeutic parameters of the 308-nm laser, location of disease, and outcomes. Long-term outcomes were analyzed in 2021, through chart review addressing 80% of the body and 61.7% of the extremities; an average of 3.38 years of follow-up was recorded. During that time, re-pigmentation was observed in 80% of facial, 40% of body, and 20% of extremity lesions. “Patients and parents should be counseled on the likelihood of long-term retention of re-pigmentation and regarding the need for the ongoing management of vitiligo even after re-pigmentation is initially achieved after 308-nm laser therapy,” the study authors wrote.
